Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 605430
                    [Title] => Roche acquires Biolmagene for $100 million
                    [Summary] => 
Roche announced that it has signed an agreement under which Ventana Medical Systems Inc., a member of the Roche Group, will acquire 100 percent of BioImagene, Inc., a privately held company based in Sunnyvale, California. 
                    [DatePublished] => 2010-08-25 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

        )

)

HANY MASSARANY

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 605430
                    [Title] => Roche acquires Biolmagene for $100 million
                    [Summary] => 
Roche announced that it has signed an agreement under which Ventana Medical Systems Inc., a member of the Roche Group, will acquire 100 percent of BioImagene, Inc., a privately held company based in Sunnyvale, California. 
                    [DatePublished] => 2010-08-25 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

        )

)

abtest

Roche acquires Biolmagene for $100 million

August 25, 2010 - 12:00am

Roche announced that it has signed an agreement under which Ventana Medical Systems Inc., a member of the Roche Group, will acquire 100 percent of BioImagene, Inc., a privately held company based in Sunnyvale,...

Business